Skip to main content

Overweight and Its Relation to CHD

UNDERSTANDING CORONARY HEART DISEASE (CHD)

According to current estimates, 64.4 million Americans have one or more types of cardiovascular disease. Within cardiovascular diseases, coronary heart disease (CHD) is the single largest killer of Americans. CHD caused 502,189 deaths in the US in 2001 – about 1 in every 5. The American Heart Association estimates that 13.2 million Americans have CHD. In fact, up to half of all sudden, out-of-hospital cardiac deaths occur in people with no prior diagnosis of heart disease, and over two-thirds of heart attach sufferers have blockages in their arteries considered to be clinically “insignificant” in terms of plaque burden and percent stenosis. Until recently, it was widely held that most heart attacks were caused by a gradual build-up of atherosclerotic plaque within the arteries of the heart (“hardening of the arteries”), impedes blood flow, and eventually results in blocked blood vessels that can cause acute ischemic events such as unstable angina, heart attack, stroke, peripheral vascular disease, and a variety of other related debilitating conditions.


Source: Association for the Eradication of Heart Attack

Scientists now know that life-threatening cardiac events are very often linked to unstable, rupture-prone arterial deposits known as “vulnerable plaques.” These unstable plaques are associated with enlargement of the arterial vessel wall, and consist of soft, biologically active, thrombogenic fatty material covered by a thin fibrous cap and characterized by a large infiltration of activated macrophages, indicating a high level of inflammation. Inflammation leads to an accumulation of proteolytic enzymes, which leads to a breakdown or sudden rupture of the fibrous cap, without warning, resulting in the release or erosion of the fatty lipid core into the blood stream. Exposure to the thromboemboli cascade promotes the formation of blood clots that can cause acute ischemic events, such as unstable angina or myocardial infarction.

Researchers believe that these vulnerable plaques are responsible for 85% or more of all heart attacks, and that the same types of plaque deposits in the carotid and cerebral arteries may account for the majority of ischemic strokes.

Comments

Post a Comment

Popular posts from this blog

Exercise and proper sleep can reduce cancer risk

The latest research shows that proper exercise which should be regulated ( Like 30mins daily ) and proper sleep can reduce cancer risks. Because, daily exercise maintains body metabolism in a steady way and this prevents altered metabolism within our body. Also, proper sleep which should be at least 6 hours at night can reduces the altered endocrine and metabolic functions. So, proper sleep is very important. This all can reduce cancer risks upto 55%.
Post a Comment
Read more

Treatment with stem cells, a new era in medical science.......

A new Era is coming forward in the treatment of human body. That is the STEM CELL THERAPY. If this treatment comes forward then medical science can treat many of those major diseases that are killing a large number of people each year. There are many diseases now that can't be cured by medical treatment, like Paralysis . If a patient has paralysis then doctors give him only some supportive treatment to improve his nerve supply on that affected area. But it can't give a redical cure. Because if a nerve cell damaged it cant be regenerated due to it is mane if stable cells. But, if a stem cell is replaced on that area then it can regenerate a nerve cell because stem cell can grow in the form of any cells or tissues, it has that capacity. Although a stem cell can grow in any form of a tissue or an organ. So, if we can place a stem cell in that affected hand or leg then this stem cell will grow under control and can regenerate into that original tissue. So, the patient will be cu...
Post a Comment
Read more

Artificial pancreas ... an option

Coming Soon: 'Artificial Pancreas' Options for Diabetes Miriam E Tucker June 20, 2016   NEW ORLEANS — Nearly closed-loop systems (also referred to as an "artificial pancreas") for improving glycemic control and minimizing hypoglycemia in type 1 diabetes are advancing rapidly, including iterations that deliver insulin alone, insulin with glucagon, or glucagon alone. Findings for several of the products in development demonstrating improvements in glycemic control and reductions in hypoglycemia were presented here at the  American Diabetes Association (ADA) 2016 Scientific Sessions . "Some people may do well on insulin only, while others may need glucagon," Vincent Crabtree, PhD, director of the artificial pancreas program at JDRF, in New York, told  Medscape Medical News , adding, "JDRF would like people to have choice, and we'd like all to be covered [by payers]." The insulin-only hybrid closed-loop 670G system (Medtronic MiniMed) is the...
Post a Comment
Read more